Download PDF
Semin Respir Crit Care Med 2022; 43(06): 839-850
DOI: 10.1055/s-0042-1757885
Review Article

Lung Cancer Screening

Elizabeth Lee
,
Ella A. Kazerooni
› Further Information
    Permissions and Reprints

Abstract

Lung cancer is a leading cause of cancer death in the United States and globally with the majority of lung cancer cases attributable to cigarette smoking. Given the high societal and personal cost of a diagnosis of lung cancer including that most cases of lung cancer when diagnosed are found at a late stage, work over the past 40 years has aimed to detect lung cancer earlier when curative treatment is possible. Screening trials using chest radiography and sputum failed to show a reduction in lung cancer mortality however multiple studies using low dose CT have shown the ability to detect lung cancer early and a survival benefit to those screened. This review will discuss the history of lung cancer screening, current recommendations and screening guidelines, and implementation and components of a lung cancer screening program.

Keywords

National Lung Screening Trial - lung cancer - chest radiography


Publication History

Article published online:
28 November 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Sung H, Ferlay J, Siegel RL. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71 (03) 209-249
    Google Scholar
  • 2 International Agency for Research on Cancer. Accessed September 14, 2022 at: https://gco.iarc.fr/today/data/factsheets/cancers/15-Lung-fact-sheet.pdf
    PubMed
  • 3 Schabath MB, Cote ML. Cancer progress and priorities: lung cancer. Cancer Epidemiol Biomarkers Prev 2019; 28 (10) 1563-1579
    CrossrefPubMedGoogle Scholar
  • 4 Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin 2021; 71 (01) 7-33
    CrossrefPubMedGoogle Scholar
  • 5 Potter AL, Rosenstein AL, Kiang MV. et al. Association of computed tomography screening with lung cancer stage shift and survival in the United States: quasi-experimental study. BMJ 2022; 376: e069008
    CrossrefPubMedGoogle Scholar
  • 6 Vachani A, Carroll NM, Simoff MJ. et al. Stage migration and lung cancer incidence after initiation of low-dose CT screening. J Thorac Oncol 2022; ( epub ahead of print) DOI: 10.1016/j.jtho.2022.08.011.
    CrossrefPubMedGoogle Scholar
  • 7 Gierada DS, Black WC, Chiles C, Pinsky PF, Yankelevitz DF. Low-dose CT screening for lung cancer: evidence from 2 decades of study. Radiol Imaging Cancer 2020; 2 (02) e190058
    CrossrefPubMedGoogle Scholar
  • 8 Aberle DR, Adams AM, Berg CD. et al; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365 (05) 395-409
    CrossrefPubMedGoogle Scholar
  • 9 National Lung Screening Trial Research Team. Lung cancer incidence and mortality with extended follow-up in the National Lung Screening Trial. J Thorac Oncol 2019; 14 (10) 1732-1742
    CrossrefPubMedGoogle Scholar
  • 10 de Koning HJ, van der Aalst CM, de Jong PA. et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 2020; 382 (06) 503-513
    CrossrefPubMedGoogle Scholar
  • 11 Tockman M. Survival and mortality from lung cancer in a screened population: The Johns Hopkins Study. Chest 1986; 89 (04) 324S-325S
    CrossrefPubMedGoogle Scholar
  • 12 Melamed MR, Flehinger BJ, Zaman MB, Heelan RT, Perchick WA, Martini N. Screening for early lung cancer. Results of the memorial Sloan-Kettering study in New York. Chest 1984; 86 (01) 44-53
    PubMedGoogle Scholar
  • 13 Doria-Rose VP, Marcus PM, Szabo E, Tockman MS, Melamed MR, Prorok PC. Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study. Cancer 2009; 115 (21) 5007-5017
    CrossrefPubMedGoogle Scholar
  • 14 Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR. Lung cancer screening: the Mayo program. J Occup Med 1986; 28 (08) 746-750
    CrossrefPubMedGoogle Scholar
  • 15 Kubik A, Parkin DM, Khlat M, Erban J, Polak J, Adamec M. Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia. Int J Cancer 1990; 45 (01) 26-33
    CrossrefPubMedGoogle Scholar
  • 16 Oken MM, Hocking WG, Kvale PA. et al; PLCO Project Team. Screening by chest radiograph and lung cancer mortality: the prostate, lung, colorectal, and ovarian (PLCO) randomized trial. JAMA 2011; 306 (17) 1865-1873
    CrossrefPubMedGoogle Scholar
  • 17 Henschke CI, McCauley DI, Yankelevitz DF. et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999; 354 (9173): 99-105
    CrossrefPubMedGoogle Scholar
  • 18 New York Early Lung Cancer Action Project Investigators. CT screening for lung cancer: diagnoses resulting from the New York Early Lung Cancer Action Project. Radiology 2007; 243 (01) 239-249
    CrossrefPubMedGoogle Scholar
  • 19 Tabár L, Vitak B, Chen TH. et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 2011; 260 (03) 658-663
    CrossrefPubMedGoogle Scholar
  • 20 Infante M, Cavuto S, Lutman FR. et al; DANTE Study Group. Long-term follow-up results of the DANTE Trial, a randomized study of lung cancer screening with spiral computed tomography. Am J Respir Crit Care Med 2015; 191 (10) 1166-1175
    CrossrefPubMedGoogle Scholar
  • 21 Wille MMW, Dirksen A, Ashraf H. et al. Results of the rndomized Danish Lung Cancer Screening Trial with focus on high-risk profiling. Am J Respir Crit Care Med 2016; 193 (05) 542-551
    CrossrefPubMedGoogle Scholar
  • 22 Pastorino U, Silva M, Sestini S. et al. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy. Ann Oncol 2019; 30 (07) 1162-1169
    CrossrefPubMedGoogle Scholar
  • 23 Moyer VA. U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014; 160 (05) 330-338
    CrossrefPubMedGoogle Scholar
  • 24 Krist AH, Davidson KW, Mangione CM. et al; US Preventive Services Task Force. Screening for lung cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2021; 325 (10) 962-970
    CrossrefPubMedGoogle Scholar
  • 25 Haiman CA, Stram DO, Wilkens LR. et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med 2006; 354 (04) 333-342
    CrossrefPubMedGoogle Scholar
  • 26 Aldrich MC, Mercaldo SF, Sandler KL, Blot WJ, Grogan EL, Blume JD. Evaluation of USPSTF lung cancer screening guidelines among African American adult smokers. JAMA Oncol 2019; 5 (09) 1318-1324
    CrossrefPubMedGoogle Scholar
  • 27 Kaplan RC, Bangdiwala SI, Barnhart JM. et al. Smoking among U.S. Hispanic/Latino adults: the Hispanic community health study/study of Latinos. Am J Prev Med 2014; 46 (05) 496-506
    CrossrefPubMedGoogle Scholar
  • 28 Bandiera FC, Assari S, Livaudais-Toman J, Pérez-Stable EJ. Latino and Black smokers in the Health and Retirement Study are more likely to quit: the role of light smoking. Tob Induc Dis 2016; 14: 23
    CrossrefPubMedGoogle Scholar
  • 29 Trivedi AN, Rakowski W, Ayanian JZ. Effect of cost sharing on screening mammography in Medicare health plans. N Engl J Med 2008; 358 (04) 375-383
    CrossrefPubMedGoogle Scholar
  • 30 Zhao J, Mao Z, Fedewa SA. et al. The affordable care act and access to care across the cancer control continuum: a review at 10 years. CA Cancer J Clin 2020; 70 (03) 165-181
    CrossrefPubMedGoogle Scholar
  • 31 American Academy of Family Physicians. Clinical Preventive Service Recommendation: Lung Cancer Screening, Adult, 2021. Accessed September 15, 2022 at: https://www.aafp.org/family-physician/patient-care/clinical-recommendations/all-clinical-recommendations/lung-cancer.html
    PubMedGoogle Scholar
  • 32 NCCN Clinical Practice Guidelines in Oncology. Lung Cancer Screening V2.2022, July 19 2022. Accessed September 15, 2022 at: https://www.nccn.org/guidelines/category_2
    PubMedGoogle Scholar
  • 33 Tindle HA, Duncan MS, Greevy RA. et al. Lifetime smoking history and risk of lung cancer: results from the Framingham Heart Study. J Natl Cancer Inst 2018; 110 (11) 1201-1207
    PubMedGoogle Scholar
  • 34 Ebbert JO, Yang P, Vachon CM. et al. Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women. J Clin Oncol 2003; 21 (05) 921-926
    CrossrefPubMedGoogle Scholar
  • 35 Silvestri GA, Goldman L, Burleson J. et al. Characteristics of Persons Screened for Lung Cancer in the United States. Ann Int Med 2022; (e-pub ahead of print) DOI: 10.7326/M22-1325.
    CrossrefPubMedGoogle Scholar
  • 36 Sahar L, Wills VLD, Liu KKA. et al. Geographic access to lung cancer screening among eligible adults living in rural and urban environments in the United States. Cancer 2022; 128 (08) 1584-1594
    CrossrefPubMedGoogle Scholar
  • 37 Wiener RS, Gould MK, Arenberg DA. et al; ATS/ACCP Committee on Low-Dose CT Lung Cancer Screening in Clinical Practice. An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice. Am J Respir Crit Care Med 2015; 192 (07) 881-891
    CrossrefPubMedGoogle Scholar
  • 38 Klabunde CN, Marcus PM, Silvestri GA. et al. U.S. primary care physicians' lung cancer screening beliefs and recommendations. Am J Prev Med 2010; 39 (05) 411-420
    CrossrefPubMedGoogle Scholar
  • 39 Klabunde CN, Marcus PM, Han PKJ. et al. Lung cancer screening practices of primary care physicians: results from a national survey. Ann Fam Med 2012; 10 (02) 102-110
    CrossrefPubMedGoogle Scholar
  • 40 Coughlin JM, Zang Y, Terranella S. et al. Understanding barriers to lung cancer screening in primary care. J Thorac Dis 2020; 12 (05) 2536-2544
    CrossrefPubMedGoogle Scholar
  • 41 Ahsan A, Zimmerman E, Rodriguez EM. et al. Examining lung cancer screening behaviors in the primary care setting: a mixed methods approach. J Cancer Treat Res 2019; 7 (01) 1-8
    CrossrefPubMedGoogle Scholar
  • 42 Triplette M, Wenger DS, Shahrir S. et al. Patient identification of lung cancer screening follow-up recommendations and the association with adherence. Ann Am Thorac Soc 2022; 19 (05) 799-806
    CrossrefPubMedGoogle Scholar
  • 43 Hansberry DR, White MD, D'Angelo M. et al. Lung Cancer Screening Guidelines: how readable are internet-based patient education resources?. AJR Am J Roentgenol 2018; 211 (01) W42-W46
    CrossrefPubMedGoogle Scholar
  • 44 Haas K, Brillante C, Sharp L. et al. Lung cancer screening: assessment of health literacy and readability of online educational resources. BMC Public Health 2018; 18 (01) 1356
    CrossrefPubMedGoogle Scholar
  • 45 GO2 Foundation for Lung Cancer, Care Continuum Centers of Excellence (CCCOE). Accessed September 15, 2022 at: https://go2foundation.org/treatments-and-side-effects/centers-of-excellence/
    PubMed
  • 46 American College of Radiology Lung Cancer Screening Resources. Accessed September 15, 2022 at: https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources
    PubMed
  • 47 Sakoda LC, Rivera MP, Zhang J. et al. Patterns and factors associated with adherence to lung cancer screening in diverse practice settings. JAMA Netw Open 2021; 4 (04) e218559
    CrossrefPubMedGoogle Scholar
  • 48 Geber DE, Gillam AO, Hamann HA. Lung cancer screening in the “real world” and the role of nurse navigators. J Oncol Navig Surviv 2013;04(02)
    PubMedGoogle Scholar
  • 49 Hoopes SM, Weathers J, Perkins L. et al. The importance of nurse navigation in lung cancer screening. J Oncol Navig Surviv 2018;9(11)
    PubMedGoogle Scholar
  • 50 Shusted CS, Barta JA, Lake M. et al. The case for patient navigation in lung cancer screening in vulnerable populations: a systematic review. Popul Health Manag 2019; 22 (04) 347-361
    CrossrefPubMedGoogle Scholar
  • 51 Christie J, Itzkowitz S, Lihau-Nkanza I, Castillo A, Redd W, Jandorf L. A randomized controlled trial using patient navigation to increase colonoscopy screening among low-income minorities. J Natl Med Assoc 2008; 100 (03) 278-284
    PubMedGoogle Scholar
  • 52 Kunos CA, Olszewski S, Espinal E. Impact of nurse navigation on timeliness of diagnostic medical services in patients with newly diagnosed lung cancer. J Community Support Oncol 2015; 13 (06) 219-224
    CrossrefPubMedGoogle Scholar
  • 53 Alsamarai S, Yao X, Cain HC. et al. The effect of a lung cancer care coordination program on timeliness of care. Clin Lung Cancer 2013; 14 (05) 527-534
    CrossrefPubMedGoogle Scholar
  • 54 Braun KL, Thomas Jr. WL, Domingo JL. et al. Reducing cancer screening disparities in medicare beneficiaries through cancer patient navigation. J Am Geriatr Soc 2015; 63 (02) 365-370
    CrossrefPubMedGoogle Scholar
  • 55 Patient Navigator Training Collaborative. Lung Cancer Screening Course for Patient Navigators. Accessed September 15, 2022 at: https://patientnavigatortraining.org/elearning/courses/lung-cancer-screening/
    PubMedGoogle Scholar
  • 56 Spalluto LB, Lewis JA, LaBaze S. et al. Association of a lung screening program coordinator with adherence to annual CT lung screening at a large academic institution. J Am Coll Radiol 2020; 17 (02) 208-215
    CrossrefPubMedGoogle Scholar
  • 57 Gilbert CR, Ely R, Fathi JT. et al. The economic impact of a nurse practitioner-directed lung cancer screening, incidental pulmonary nodule, and tobacco-cessation clinic. J Thorac Cardiovasc Surg 2018; 155 (01) 416-424
    CrossrefPubMedGoogle Scholar
  • 58 Fathi JT, White CS, Greenberg GM, Mazzone PJ, Smith RA, Thomson CC. The integral role of the electronic health record and tracking software in the implementation of lung cancer screening—a call to action to developers: a white paper from the National Lung Cancer Roundtable. Chest 2020; 157 (06) 1674-1679
    CrossrefPubMedGoogle Scholar
  • 59 LungPlan Overview. National Lung Cancer Roundtable at the American Cancer Society. Accessed September 15, 2022 at: https://nlcrt.org/lungplan-overview/
    PubMedGoogle Scholar
  • 60 American College of Radiology-Society of Thoracic Radiology practice parameter for the performance and reporting of lung cancer screening thoracic computed tomography (CT) 2019. Accessed September 15, 2022 at: https://www.acr.org/-/media/ACR/Files/Practice-Parameters/CT-LungCaScr.pdf accessed on line 9/15/2022
    PubMedGoogle Scholar
  • 61 Lung Cancer Screening CT Protocols Version 5.1 13 September 2019. American Association of Physicists in Medicine. Accessed September 15, 2022 at: https://www.aapm.org/pubs/ctprotocols/documents/lungcancerscreeningct.pdf
    PubMedGoogle Scholar
  • 62 Kawel N, Seifert B, Luetolf M, Boehm T. Effect of slab thickness on the CT detection of pulmonary nodules: use of sliding thin-slab maximum intensity projection and volume rendering. AJR Am J Roentgenol 2009; 192 (05) 1324-1329
    CrossrefPubMedGoogle Scholar
  • 63 Rubin GD. Lung nodule and cancer detection in computed tomography screening. J Thorac Imaging 2015; 30 (02) 130-138
    CrossrefPubMedGoogle Scholar
  • 64 Yip R, Henschke CI, Yankelevitz DF, Smith JP. CT screening for lung cancer: alternative definitions of positive test result based on the national lung screening trial and international early lung cancer action program databases. Radiology 2014; 273 (02) 591-596
    CrossrefPubMedGoogle Scholar
  • 65 Lung CT Screening reporting & Data System (Lung-RADS). Accessed September 15, 2022 at: https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/Lung-Rads
    PubMedGoogle Scholar
  • 66 Han D, Heuvelmans MA, Oudkerk M. Volume versus diameter assessment of small pulmonary nodules in CT lung cancer screening. Transl Lung Cancer Res 2017; 6 (01) 52-61
    CrossrefPubMedGoogle Scholar
  • 67 Kauczor HU, Baird AM, Blum TG. et al; European Society of Radiology (ESR) and the European Respiratory Society (ERS). ESR/ERS statement paper on lung cancer screening. Eur Respir J 2020; 55 (02) 190050
    CrossrefPubMedGoogle Scholar
  • 68 Hammer MM, Byrne SC. Cancer risk in nodules detected at follow-up lung cancer screening CT. AJR Am J Roentgenol 2022; 218 (04) 634-641
    CrossrefPubMedGoogle Scholar
  • 69 de Hoop B, van Ginneken B, Gietema H, Prokop M. Pulmonary perifissural nodules on CT scans: rapid growth is not a predictor of malignancy. Radiology 2012; 265 (02) 611-616
    CrossrefPubMedGoogle Scholar
  • 70 Xu DM, van der Zaag-Loonen HJ, Oudkerk M. et al. Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up. Radiology 2009; 250 (01) 264-272
    CrossrefPubMedGoogle Scholar
  • 71 Zhu Y, Yip R, You N, Henschke CI, Yankelevitz DF. Management of nodules attached to the costal pleura at low-dose CT screening for lung cancer. Radiology 2020; 297 (03) 710-718
    CrossrefPubMedGoogle Scholar
  • 72 Zhu Y, Cai Q, Yip R. et al. Radiologic features of nodules attached to the mediastinal or diaphragmatic pleura. International Association for the Study of Lung Cancer 2022 World Congress on Lung Cancer, EP01.05–011, abstract book page 371; Accessed September 30, 2022 at: https://wclc2022.iaslc.org/wp-content/uploads/2022/07/WCLC2022-Abstract-Book.pdf%20access%209/15/2022
    PubMedGoogle Scholar
  • 73 Henschke CI. International Early Lung Cancer Action Program: Screening Protocol, January 15, 2022. Accessed September 15, 2022 at: https://www.ielcap.org/sites/default/files/I-ELCAP-protocol.pdf
    PubMedGoogle Scholar
  • 74 Xu DM, Gietema H, de Koning H. et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 2006; 54 (02) 177-184
    CrossrefPubMedGoogle Scholar
  • 75 Dyer DS, Gieske MR, Kazerooni EA. et al. A quick reference guide for incidental findings on lung cancer screening CT examinations. Journal of the American College of Radiology In Press. Accessed September 15, 2022 at: https://www.acr.org/-/media/ACR/Files/Lung-Cancer-Screening-Resources/LCS-Incidental-Findings-Quick-Guide.pdf
    PubMedGoogle Scholar
  • 76 Bach PB, Mirkin JN, Oliver TK. et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012; 307 (22) 2418-2429
    CrossrefPubMedGoogle Scholar
  • 77 Mazzone PJ, White CS, Kazerooni EA, Smith RA, Thomson CC. Proposed quality metrics for lung cancer screening programs: a national lung cancer roundtable project. Chest 2021; 160 (01) 368-378
    CrossrefPubMedGoogle Scholar
  • 78 The American College of Radiology Lung Cancer Screening Registry. American College of Radiology. Accessed September 15, 2022 at: https://www.acr.org/Practice-Management-Quality-Informatics/Registries/Lung-Cancer-Screening-Registry
    PubMedGoogle Scholar